Comment on “Anti-NMDA receptor encephalitis presenting as new onset refractory status epilepticus in COVID-19”

Detalles Bibliográficos
Autores principales: Dinoto, Alessandro, Cheli, Marta, Sartori, Arianna, Manganotti, Paolo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: British Epilepsy Association. Published by Elsevier Ltd. 2020
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7425771/
https://www.ncbi.nlm.nih.gov/pubmed/32827979
http://dx.doi.org/10.1016/j.seizure.2020.08.007
_version_ 1783570560736821248
author Dinoto, Alessandro
Cheli, Marta
Sartori, Arianna
Manganotti, Paolo
author_facet Dinoto, Alessandro
Cheli, Marta
Sartori, Arianna
Manganotti, Paolo
author_sort Dinoto, Alessandro
collection PubMed
description
format Online
Article
Text
id pubmed-7425771
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher British Epilepsy Association. Published by Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-74257712020-08-14 Comment on “Anti-NMDA receptor encephalitis presenting as new onset refractory status epilepticus in COVID-19” Dinoto, Alessandro Cheli, Marta Sartori, Arianna Manganotti, Paolo Seizure Letter to the Editor British Epilepsy Association. Published by Elsevier Ltd. 2020-10 2020-08-13 /pmc/articles/PMC7425771/ /pubmed/32827979 http://dx.doi.org/10.1016/j.seizure.2020.08.007 Text en © 2020 British Epilepsy Association. Published by Elsevier Ltd. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Letter to the Editor
Dinoto, Alessandro
Cheli, Marta
Sartori, Arianna
Manganotti, Paolo
Comment on “Anti-NMDA receptor encephalitis presenting as new onset refractory status epilepticus in COVID-19”
title Comment on “Anti-NMDA receptor encephalitis presenting as new onset refractory status epilepticus in COVID-19”
title_full Comment on “Anti-NMDA receptor encephalitis presenting as new onset refractory status epilepticus in COVID-19”
title_fullStr Comment on “Anti-NMDA receptor encephalitis presenting as new onset refractory status epilepticus in COVID-19”
title_full_unstemmed Comment on “Anti-NMDA receptor encephalitis presenting as new onset refractory status epilepticus in COVID-19”
title_short Comment on “Anti-NMDA receptor encephalitis presenting as new onset refractory status epilepticus in COVID-19”
title_sort comment on “anti-nmda receptor encephalitis presenting as new onset refractory status epilepticus in covid-19”
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7425771/
https://www.ncbi.nlm.nih.gov/pubmed/32827979
http://dx.doi.org/10.1016/j.seizure.2020.08.007
work_keys_str_mv AT dinotoalessandro commentonantinmdareceptorencephalitispresentingasnewonsetrefractorystatusepilepticusincovid19
AT chelimarta commentonantinmdareceptorencephalitispresentingasnewonsetrefractorystatusepilepticusincovid19
AT sartoriarianna commentonantinmdareceptorencephalitispresentingasnewonsetrefractorystatusepilepticusincovid19
AT manganottipaolo commentonantinmdareceptorencephalitispresentingasnewonsetrefractorystatusepilepticusincovid19

Ejemplares similares